Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Amortization - Intangibles: 2014-2024

Historic Amortization - Intangibles for Ligand Pharmaceuticals (LGND) over the last 11 years, with Dec 2024 value amounting to $33.0 million.

  • Ligand Pharmaceuticals' Amortization - Intangibles fell 1.95% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.9 million, marking a year-over-year decrease of 0.53%. This contributed to the annual value of $33.0 million for FY2024, which is 2.08% down from last year.
  • According to the latest figures from FY2024, Ligand Pharmaceuticals' Amortization - Intangibles is $33.0 million, which was down 2.08% from $33.7 million recorded in FY2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Amortization - Intangibles peaked at $34.2 million during FY2022, and registered a low of $11.6 million during FY2020.
  • Over the past 3 years, Ligand Pharmaceuticals' median Amortization - Intangibles value was $33.7 million (recorded in 2023), while the average stood at $33.6 million.
  • Per our database at Business Quant, Ligand Pharmaceuticals' Amortization - Intangibles tumbled by 30.97% in 2020 and then spiked by 193.95% in 2021.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Amortization - Intangibles stood at $11.6 million in 2020, then soared by 193.95% to $34.2 million in 2021, then rose by 0.04% to $34.2 million in 2022, then dropped by 1.57% to $33.7 million in 2023, then decreased by 2.08% to $33.0 million in 2024.